Plasma proteomic signatures of cerebrovascular disease
We report plasma proteomic signatures for CeVD. Further studies are required to evaluate the mechanistic underpinnings of these plasma biomarkers as therapeutic targets for CeVD pathology. References 1. Elahi, et al. Stroke 2023.
Authors
- Mark Richards (ORCID: https://orcid.org/0000-0002-2023-8177)
- Eugene S.J. Tan (ORCID: https://orcid.org/0000-0001-7273-6883)
- Ming Ann Sim (ORCID: https://orcid.org/0000-0002-5699-3553)
- Yuan Cai (ORCID: https://orcid.org/0000-0002-7551-2866)
- Hyung Won Choi
- Christopher Chen
- Saima Hilal
Institutions
- National University of Singapore (SG)
- Chinese University of Hong Kong (HK)
- Erasmus MC (NL)
- New Zealand Brain Research Institute (NZ)
- National University Heart Centre Singapore (SG)
- National University Hospital (SG)
- National Heart Centre Singapore (SG)
- National University Health System (SG)
- University of Otago (NZ)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_103352
- Primary Topic
- Advanced Proteomics Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00